This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Mar;8(3):123.

doi: 10.1038/nrcardio.2011.5.

Atrial fibrillation: RE-LY: dabigatran in cardioversion

PMID: 21475324
DOI: 10.1038/nrcardio.2011.5

Comment

Atrial fibrillation: RE-LY: dabigatran in cardioversion

Katrina Ray. Nat Rev Cardiol. 2011 Mar.

. 2011 Mar;8(3):123.

doi: 10.1038/nrcardio.2011.5.

Author

PMID: 21475324
DOI: 10.1038/nrcardio.2011.5

No abstract available

PubMed Disclaimer

Comment on

Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion.
Nagarakanti R, Ezekowitz MD, Oldgren J, Yang S, Chernick M, Aikens TH, Flaker G, Brugada J, Kamensky G, Parekh A, Reilly PA, Yusuf S, Connolly SJ. Nagarakanti R, et al. Circulation. 2011 Jan 18;123(2):131-6. doi: 10.1161/CIRCULATIONAHA.110.977546. Epub 2011 Jan 3. Circulation. 2011. PMID: 21200007 Clinical Trial.

References

1. Circulation. 2011 Jan 18;123(2):131-6 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.